Product Information

MICROGESTIN 21 1-20 TABLET is a generic product labeled by Mayne Pharma, priced at $0.1703 per EA under NDC 51862086801. Its NADAC has been published 211 times since Oct 20, 2021.

MICROGESTIN 21 1-20 TABLET

Norethindrone Acetate/Ethinyl Estradiol
$0.1703per EA

Manufacturer

Mayne Pharma

NDC

51862086801

Classification

Generic

Dosage Form

KIT

Last Updated

10/22/2025

Approval Type

Generic (ANDA)

FDA Application

ANDA202995

On Market Since

10/12/2020

Price Statistics

The NADAC for MICROGESTIN 21 1-20 TABLET has been published 211 times since Oct 20, 2021, and over the history we have for it it has declined 47.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1703 per EA
All-time high$0.3286 (Dec 15, 2021)
All-time low$0.1619 (Nov 20, 2024)
52-week high$0.1797
52-week low$0.1703
Median price$0.2395
Average price$0.2354
Largest weekly change+34.5% (Aug 21, 2024)
Weeks tracked211
Tracking sinceOct 20, 2021

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

-5.2%

3Y

-34.8%

5Y

N/A

All

-47.7%

Generic Alternatives

The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of MICROGESTIN 21 1-20 TABLET?

The current National Average Drug Acquisition Cost (NADAC) for MICROGESTIN 21 1-20 TABLET, manufactured by Mayne Pharma, is $0.1703 per EA (NDC 51862086801), effective Oct 29, 2025.

How has the price of MICROGESTIN 21 1-20 TABLET changed over time?

Over the history we have for it, the NADAC for MICROGESTIN 21 1-20 TABLET has declined 47.7%. It has been tracked across 211 weekly CMS publications since Oct 20, 2021.

What are the highest and lowest recorded NADAC prices for MICROGESTIN 21 1-20 TABLET?

Since Oct 20, 2021, the NADAC for MICROGESTIN 21 1-20 TABLET has ranged from a low of $0.1619 (Nov 20, 2024) to a high of $0.3286 (Dec 15, 2021), with a median of $0.2395 per EA.

Are there cheaper alternatives to MICROGESTIN 21 1-20 TABLET?

3 NADAC-published products share the same active ingredient, strength, and dosage form as MICROGESTIN 21 1-20 TABLET, but none are currently priced below it.

Who manufactures MICROGESTIN 21 1-20 TABLET?

MICROGESTIN 21 1-20 TABLET (NDC 51862086801) is labeled by Mayne Pharma, and CMS classifies it as a generic product.

Related Drugs

Same classification

No related drugs found.